Therapeutic Antibodies
-
-
The CPRIT Therapeutic Antibody Core
We offer Texas-wide access to specialized technical expertise, instrumentation, and automation to advance lead antibodies with “drug like” properties from academic laboratories to the stage of preclinical development.
-
Therapeutic Antibody Development
Lead Identification – Lead Optimization – Lead Construction – Antibody Production
An earns National Academy of Inventors fellowship
January 3, 2022 | Roman Petrowski, McGovern Medical School
GSBS faculty member Zhiqiang An, PhD, has been named a fellow of the National Academy of Inventors (NAI), the organization announced Dec. 7. The NAI Fellows Program highlights academic inventors who have demonstrated a spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society. Election to NAI Fellow is the highest professional distinction accorded solely to academic inventors.
Tumors May Shed Protein to Create Barriers that Block Immune Cells
December 10, 2021 | NCI Staff
Scientists have identified a protein that may help prevent immune cells from entering breast tumors and killing the cancer cells. The research, which was conducted primarily in mice, could lead to potential strategies for overcoming barriers that keep certain immune cells from attacking tumors, according to the investigators.
Research on antibody-drug conjugates shows promise in fighting breast cancer
June 16, 2021 | Roman Petrowski, Office of Communications
Research from the lab of Kyoji Tsuchikama, PhD, assistant professor in the Texas Therapeutics Institute at The Brown Foundation Institute of Molecular Medicine, on a new potential treatment for combating breast cancer has been published in the June edition of Nature Communications.
